Suspension of trading

Business Segments Masimo Corporation

Stocks

Market Closed - Nasdaq 00:00:00 10/06/2026 +04			5-day change	1st Jan Change
179.95 ^USD	+0.01%		-.--%	+38.36%

08-25	Masimo Receives FDA 510(k) Clearance for Root with LiDCO and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery	CI
08-04	Masimo Appoints Tim Benner as President, Effective August 3, 2026	CI

Breakdown by Business Segment (USD)

Fiscal Period: January	2021	2022	2023	2024	2025
Medical Testing, Analyzing, and Diagnostic Equipment
Healthcare	-	1.34B	1.28B	1.4B	1.52B
Total Assets	-	1.59B	1.63B	1.6B	1.7B
Gross Profit	-	870M	777M	874M	950M
D&A	-	36M	38.1M	48.7M	38.8M
Patient Monitoring and Related Products	1.24B	-	-	-	-
Total Assets	1.89B	-	-	-	-
Interest Expense	-355K	-	-	-	-
Income Tax Expense	44.73M	-	-	-	-
CAPEX	-34.93M	-	-	-	-
EBT	274M	-	-	-	-
Gross Profit	808M	-	-	-	-
D&A	35.62M	-	-	-	-
Operating Income	276M	-	-	-	-
Net Income	230M	-	-	-	-
	-	-	-	-	1.52B
Other	-	-	-	-	2.8M
Gross Profit	-	-63.9M	-31.6M	-	-
Total Assets	-	-	-	17.4M	1.1M
	-	-	-	-	2.8M
Total Assets	-	19M	19.1M	-	-
Audio Equipment
Non-healthcare	-	696M	773M	699M	-
Total Assets	-	1.6B	1.39B	1.01B	-
Gross Profit	-	252M	258M	235M	-
D&A	-	100M	60.1M	54.3M	-

Geographical breakdown of sales (USD)

Fiscal Period: January	2021	2022	2023	2024	2025
United States (U.S.)	822M	1.14B	1.06B	1.13B	957M
Total Assets	239M	320M	318M	320M	308M
	-	-	-	-	120M
Europe, Middle East and Africa	252M	524M	572M	596M	391M
	-	-	-	-	59.3M
Asia and Australia	124M	327M	351M	304M	120M
	-	-	-	-	391M
North and South America (Excluding United States)	41.31M	43.7M	66.4M	67.7M	59.3M
Unallocated	-	-	-	-	-
	-	-	-	-	957M
Total Assets	36.05M	84.5M	108M	80.6M	48.2M